loadpatents
Patent applications and USPTO patent grants for Balog; James Aaron.The latest application filed is for "radioligands for imaging the id01 enzyme".
Patent | Date |
---|---|
Radioligands For Imaging The Id01 Enzyme App 20220305144 - Donnelly; David J. ;   et al. | 2022-09-29 |
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Grant 11,447,449 - Balog , et al. September 20, 2 | 2022-09-20 |
Immunoregulatory Agents App 20220274926 - BECK; Hilary Plake ;   et al. | 2022-09-01 |
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Grant 11,351,164 - Zhang , et al. June 7, 2 | 2022-06-07 |
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Grant 11,337,970 - Cherney , et al. May 24, 2 | 2022-05-24 |
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Grant 11,253,525 - Balog , et al. February 22, 2 | 2022-02-22 |
Immunoregulatory agents Grant 11,242,319 - Beck , et al. February 8, 2 | 2022-02-08 |
Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20210355113 - BALOG; James Aaron ;   et al. | 2021-11-18 |
Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20210299126 - BALOG; James Aaron ;   et al. | 2021-09-30 |
Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20210290613 - CHERNEY; Emily Charlotte ;   et al. | 2021-09-23 |
Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20210283123 - ZHANG; Liping ;   et al. | 2021-09-16 |
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Grant 11,066,392 - Balog , et al. July 20, 2 | 2021-07-20 |
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Grant 11,066,383 - Williams , et al. July 20, 2 | 2021-07-20 |
Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20210206723 - BALOG; James Aaron ;   et al. | 2021-07-08 |
Compounds Useful As Inhibitors Of Helios Protein App 20210147383 - DEGNAN; Andrew P. ;   et al. | 2021-05-20 |
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Grant 10,959,986 - Balog , et al. March 30, 2 | 2021-03-30 |
Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20210070698 - BALOG; James Aaron ;   et al. | 2021-03-11 |
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Grant 10,696,648 - Williams , et al. June 30, 2 | 2020-06-30 |
IDO inhibitors Grant 10,689,331 - Balog , et al. | 2020-06-23 |
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Grant 10,633,342 - Cherney , et al. | 2020-04-28 |
Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20200095231 - BALOG; James Aaron ;   et al. | 2020-03-26 |
Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20200069646 - Balog; James Aaron ;   et al. | 2020-03-05 |
Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20200069695 - Balog; James Aaron ;   et al. | 2020-03-05 |
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Grant 10,544,099 - Cherney , et al. Ja | 2020-01-28 |
Immunoregulatory agents Grant 10,533,014 - Beck , et al. Ja | 2020-01-14 |
Radioligands For Imaging The Ido1 Enzyme App 20190282714 - Donnelly; David J. ;   et al. | 2019-09-19 |
Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer Grant 10,399,932 - Balog , et al. Sep | 2019-09-03 |
Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer Grant 10,399,933 - Balog , et al. Sep | 2019-09-03 |
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Grant 10,323,004 - Shan , et al. | 2019-06-18 |
Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20190144416 - WILLIAMS; David K. ;   et al. | 2019-05-16 |
Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20190144417 - WILLIAMS; David K. ;   et al. | 2019-05-16 |
Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20190135758 - CHERNEY; Emily Charlotte ;   et al. | 2019-05-09 |
Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20190119216 - CHERNEY; Emily Charlotte ;   et al. | 2019-04-25 |
Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20190119215 - SHAN; Weifang ;   et al. | 2019-04-25 |
Immunoregulatory Agents App 20190092729 - BECK; Hilary Plake ;   et al. | 2019-03-28 |
Immunoregulatory agents Grant 10,206,893 - Beck , et al. Feb | 2019-02-19 |
Ido Inhibitors App 20190002402 - Balog; James Aaron ;   et al. | 2019-01-03 |
Immunoregulatory Agents App 20190002472 - Beck; Hilary Plake ;   et al. | 2019-01-03 |
IDO inhibitors Grant 10,167,254 - Balog , et al. J | 2019-01-01 |
Immunoregulatory Agents App 20180325889 - BECK; Hilary Plake ;   et al. | 2018-11-15 |
Immunoregulatory agents Grant 10,106,546 - Beck , et al. October 23, 2 | 2018-10-23 |
Immunoregulatory Agents App 20180282281 - BECK; Hilary Plake ;   et al. | 2018-10-04 |
Inhibitors Of Indoleamine-2,3-dioxygenase For The Treatment Of Cancer App 20180079712 - Balog; James Aaron ;   et al. | 2018-03-22 |
Inhibitors Of Indoleamine-2,3-dioxygenase For The Treatment Of Cancer App 20180072660 - Balog; James Aaron ;   et al. | 2018-03-15 |
IDO inhibitors Grant 9,895,330 - Markwalder , et al. February 20, 2 | 2018-02-20 |
IDO inhibitors Grant 9,790,169 - Balog , et al. October 17, 2 | 2017-10-17 |
IDO inhibitors Grant 9,765,018 - Markwalder , et al. September 19, 2 | 2017-09-19 |
IDO inhibitors Grant 9,758,492 - Markwalder , et al. September 12, 2 | 2017-09-12 |
Ido Inhibitors App 20170231999 - Balog; James Aaron ;   et al. | 2017-08-17 |
Immunoregulatory Agents App 20170197973 - Beck; Hilary Plake ;   et al. | 2017-07-13 |
Inhibitors of indoleamine 2,3-dioxygenase (IDO) Grant 9,675,571 - Balog , et al. June 13, 2 | 2017-06-13 |
Immunoregulatory Agents App 20170143649 - Beck; Hilary Plake ;   et al. | 2017-05-25 |
Immunoregulatory agents Grant 9,643,972 - Beck , et al. May 9, 2 | 2017-05-09 |
IDO inhibitors Grant 9,624,188 - Balog , et al. April 18, 2 | 2017-04-18 |
Immunoregulatory agents Grant 9,598,422 - Beck , et al. March 21, 2 | 2017-03-21 |
Substituted bicyclic heteroaryl compounds Grant 9,598,436 - Balog , et al. March 21, 2 | 2017-03-21 |
Ido Inhibitors App 20160289171 - Balog; James Aaron ;   et al. | 2016-10-06 |
Ido Inhibitors App 20160200674 - Markwalder; Jay A. ;   et al. | 2016-07-14 |
Ido Inhibitors App 20160143870 - Markwalder; Jay A ;   et al. | 2016-05-26 |
Ido Inhibitors App 20160137595 - Markwalder; Jay A. ;   et al. | 2016-05-19 |
Immunoregulatory Agents App 20160137652 - Beck; Hilary Plake ;   et al. | 2016-05-19 |
Immunoregulatory Agents App 20160137653 - Beck; Hilary Plake ;   et al. | 2016-05-19 |
Substituted Bicyclic Heteroaryl Compounds App 20160096847 - Balog; James Aaron ;   et al. | 2016-04-07 |
Ido Inhibitors App 20160060237 - Balog; James Aaron ;   et al. | 2016-03-03 |
Tricyclic heterocycle compounds Grant 9,249,157 - Shan , et al. February 2, 2 | 2016-02-02 |
Inhibitors Of Indoleamine 2,3-dioxygenase (ido) App 20160022619 - Balog; James Aaron ;   et al. | 2016-01-28 |
Imidazopyridazinyl compounds Grant 9,145,419 - Velaparthi , et al. September 29, 2 | 2015-09-29 |
Fluoroalkyl-1,4-benzodiazepinone compounds Grant 9,133,139 - Gavai , et al. September 15, 2 | 2015-09-15 |
Tricyclic Heterocycle Compounds App 20150246930 - Shan; Weifang ;   et al. | 2015-09-03 |
Fluoroalkyl-1,4-benzodiazepinone Compounds App 20150218111 - Gavai; Ashvinikumar V. ;   et al. | 2015-08-06 |
Substituted bicyclic heteroaryl compounds Grant 8,969,586 - Balog , et al. March 3, 2 | 2015-03-03 |
Sulfonamide compounds useful as CYP17 inhibitors Grant 8,916,553 - Austin , et al. December 23, 2 | 2014-12-23 |
Sulfonamide Compounds Useful As Cyp17 Inhibitors App 20140148453 - Austin; Joel Francis ;   et al. | 2014-05-29 |
Azaindazole compounds Grant 8,673,922 - Velaparthi , et al. March 18, 2 | 2014-03-18 |
Azaindazole Compounds App 20130184254 - Velaparthi; Upender ;   et al. | 2013-07-18 |
Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function Grant 8,466,171 - Shan , et al. June 18, 2 | 2013-06-18 |
Imidazopyridazinyl Compounds App 20130045980 - Velaparthi; Upender ;   et al. | 2013-02-21 |
Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function Grant 8,067,582 - Norris , et al. November 29, 2 | 2011-11-29 |
Fused Heterocyclic Compounds Useful As Modulators Of Nuclear Hormone Receptor Function App 20100331324 - Norris; Derek J. ;   et al. | 2010-12-30 |
Fused Heterocyclic Compounds Useful As Modulators Of Nuclear Hormone Receptor Function App 20100256180 - Shan; Weifang ;   et al. | 2010-10-07 |
Hexahydroimidazopyrazin-3-one compounds useful as modulators of androgen receptor function Grant 7,776,859 - Balog , et al. August 17, 2 | 2010-08-17 |
Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function Grant 7,655,688 - Salvati , et al. February 2, 2 | 2010-02-02 |
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function Grant 7,655,689 - Salvati , et al. February 2, 2 | 2010-02-02 |
Tricycloundecane compounds useful as modulators of nuclear hormone receptor function Grant 7,550,458 - Balog , et al. June 23, 2 | 2009-06-23 |
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function Grant 7,517,904 - Salvati , et al. April 14, 2 | 2009-04-14 |
Alkylene bridged sultam compounds useful as modulators of nuclear hormone receptor function Grant 7,468,439 - Shan , et al. December 23, 2 | 2008-12-23 |
Fused cyclic modulators of nuclear hormone receptor function Grant 7,432,267 - Salvati , et al. October 7, 2 | 2008-10-07 |
Fused Heterocyclic Succinimide Compounds And Analogs Thereof, Modulators Of Nuclear Hormone Receptor Function App 20080214643 - Salvati; Mark E. ;   et al. | 2008-09-04 |
Alkylene Bridged Sultam Compounds Useful As Modulators Of Nuclear Hormone Receptor Function App 20080090883 - Shan; Weifang ;   et al. | 2008-04-17 |
Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function Grant 7,342,034 - Salvati , et al. March 11, 2 | 2008-03-11 |
Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function Grant 7,291,637 - Salvati , et al. November 6, 2 | 2007-11-06 |
Spirocyclic compounds useful as modulators of nuclear hormone receptor function Grant 7,235,563 - Balog June 26, 2 | 2007-06-26 |
Hexahydroimidazopyrazin-3-one compounds useful as modulators of androgen receptor function App 20070088039 - Balog; James Aaron ;   et al. | 2007-04-19 |
Tricycloundecane compounds useful as modulators of nuclear hormone receptor function App 20070088029 - Balog; James Aaron ;   et al. | 2007-04-19 |
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function Grant 7,141,578 - Salvati , et al. November 28, 2 | 2006-11-28 |
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20060264459 - Salvati; Mark E. ;   et al. | 2006-11-23 |
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20060223832 - Salvati; Mark E. ;   et al. | 2006-10-05 |
Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function Grant 7,087,636 - Salvati , et al. August 8, 2 | 2006-08-08 |
Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20060111424 - Salvati; Mark E. ;   et al. | 2006-05-25 |
Fused cyclic modulators of nuclear hormone receptor function Grant 7,001,911 - Salvati , et al. February 21, 2 | 2006-02-21 |
Spirocyclic compounds useful as modulators of nuclear hormone receptor function App 20060019978 - Balog; James Aaron | 2006-01-26 |
Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function App 20060020002 - Salvati; Mark E. ;   et al. | 2006-01-26 |
Fused cyclic modulators of nuclear hormone receptor function App 20050282813 - Salvati, Mark E. ;   et al. | 2005-12-22 |
Fused Heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20050272799 - Salvati, Mark E. ;   et al. | 2005-12-08 |
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20050192253 - Salvati, Mark E. ;   et al. | 2005-09-01 |
Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function App 20050187273 - Salvati, Mark E. ;   et al. | 2005-08-25 |
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20040176324 - Salvati, Mark E. ;   et al. | 2004-09-09 |
Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20040087548 - Salvati, Mark E. ;   et al. | 2004-05-06 |
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20040077605 - Salvati, Mark E. ;   et al. | 2004-04-22 |
Fused cyclic modulators of nuclear hormone receptor function App 20040077606 - Salvati, Mark E. ;   et al. | 2004-04-22 |
Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function App 20030181728 - Salvati, Mark E. ;   et al. | 2003-09-25 |
Fused cyclic modulators of nuclear hormone receptor function App 20030114420 - Salvati, Mark E. ;   et al. | 2003-06-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.